Hammerer Matthias, Boxhammer Elke, Prinz Erika, Scharinger Bernhard, Wintersteller Wilfried, Hoppe Uta C
Department of Internal Medicine II, Division of Cardiology, Austria.
Department of Radiology Paracelsus Medical University of Salzburg Müllner Hauptstraße 48, 5020 Salzburg, Austria.
Int J Cardiol Heart Vasc. 2025 Jun 2;59:101710. doi: 10.1016/j.ijcha.2025.101710. eCollection 2025 Aug.
Very severe aortic stenosis (VSAS) is a critical condition with unfavourable clinical outcomes if left untreated or treated by surgical valve replacement. In contrast, after transcatheter valve implantation (TAVI) outcomes seem to be similar or - paradoxically - even better compared to severe aortic stenosis (SAS), as indicated by previous studies.
Data of patients from a single centre who underwent TAVI were retrospectively analysed. Patients with concordant AS (n = 475) were divided into SAS (n = 379) and VSAS (n = 96) groups. These groups are compared in terms of procedural (safety) and long-term (efficacy) outcomes, using propensity score matching. In addition, a review of relevant literature is provided.
After propensity score matching, 96 patients remained in each group. Procedural outcomes did not differ significantly between VSAS and SAS groups. Cox proportional hazards regression analysis showed a favourable trend toward lower overall mortality within a mean follow-up of 42 months after TAVI in the VSAS group (hazard ratio, HR, 0.668; 95 % confidence interval, CI, 0.430-1.038). This difference did not reach statistical significance (p = 0.073), however, it was significant in the subgroups of females (p = 0.045) and patients with NYHA class III (p = 0.043).
Our analysis confirms - in line with previous studies - that patients with VSAS represent a substantial subgroup and have at least as favourable or - paradoxically -even better clinical results after TAVI compared to patients with SAS. Therefore, TAVI should not be withheld from these patients.
极重度主动脉瓣狭窄(VSAS)是一种危急病症,如果不治疗或采用外科瓣膜置换术治疗,临床预后不佳。相比之下,正如先前研究所表明的,经导管瓣膜植入术(TAVI)后,与重度主动脉瓣狭窄(SAS)相比,其预后似乎相似,或者自相矛盾地甚至更好。
对来自单一中心接受TAVI的患者数据进行回顾性分析。将符合标准的主动脉瓣狭窄患者(n = 475)分为SAS组(n = 379)和VSAS组(n = 96)。采用倾向得分匹配法,对这两组在手术(安全性)和长期(有效性)预后方面进行比较。此外,还提供了相关文献综述。
倾向得分匹配后,每组各有96例患者。VSAS组和SAS组的手术预后无显著差异。Cox比例风险回归分析显示,在TAVI术后平均42个月的随访期内,VSAS组总体死亡率呈下降趋势(风险比,HR,0.668;95%置信区间,CI,0.430 - 1.038),具有良好趋势。然而,这种差异未达到统计学意义(p = 0.073),但在女性亚组(p = 0.045)和纽约心脏协会(NYHA)心功能III级患者亚组(p = 0.043)中差异具有统计学意义。
我们的分析与先前研究一致,证实VSAS患者是一个相当大的亚组,与SAS患者相比,TAVI术后至少具有同样良好甚至自相矛盾地更好的临床结果。因此,不应拒绝为这些患者进行TAVI治疗。